Resmed (RSMDF) EBT (2009 - 2026)

Resmed (RSMDF) has reported EBT for 18 consecutive years, with $474.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 3.52% year-over-year to $474.2 million; the trailing twelve-month figure through Jun 2026 stood at $1.9 billion (up 14.42% YoY), and the FY2026 full-year result was $1.9 billion, up 14.42% from the prior year.
• EBT retreated to $474.2 million in Q2 2026 per RSMDF's latest filing, from $502.3 million in the prior quarter.
• Across five years, EBT topped out at $502.3 million in Q1 2026 and bottomed at $226.3 million in Q1 2022.
• Historically, EBT has averaged $357.1 million across 5 years, with a median of $366.6 million in 2024.
• The sharpest annual moves came in 2023 and 2024: EBT decreased 5.2% in 2023, then surged 61.23% in 2024.
• Over 5 years, EBT stood at $273.7 million in 2022, then dropped by 5.2% to $259.5 million in 2023, then jumped by 61.23% to $418.3 million in 2024, then gained by 18.6% to $496.1 million in 2025, then decreased by 4.43% to $474.2 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $474.2 million, $502.3 million, and $496.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.